Proliferation index and survival in men with prostate cancer starting long-term androgen deprivation therapy in the STAMPEDE clinical trial.

Authors

null

Larissa Mendes

University College London Cancer Institute, London, United Kingdom

Larissa Mendes , Christopher D. Brawley , Emily Grist , Adnan Ali , Sara Santos Vidal , Marina Parry , Sharanpreet Lall , Nafisah B. Atako , Sofeya Ishaq , Malissa Richmond , Aine Haran , Alex Hoyle , Leila Zakka , Christopher Sweeney , Noel W. Clarke , Mahesh K. B. Parmar , Nicholas D. James , Louise C. Brown , Daniel Berney , Gerhardt Attard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5076)

DOI

10.1200/JCO.2021.39.15_suppl.5076

Abstract #

5076

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

First Author: Shunsuke Kamijo

Poster

2021 Genitourinary Cancers Symposium

Survival outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study.

Survival outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study.

First Author: Stephen J. Freedland

First Author: Joelle Helou